transparency

UNITED KINGDOM

SWEDEN
SWEDEN – ENG
NORWAY
DENMARK
GERMANY

Transparency

At AGB Pharma, we support and collaborate with a diverse range of stakeholders. Our interactions are governed by a commitment to openness and transparency, which underpins public trust and confidence. We fully disclose our relationships to demonstrate their integrity. In line with ABPI guidelines, transfers of value to members of the public – including patients and journalists – are disclosed annually (below) in aggregate.

Documentation

Methodological Note (2023)
Transfer of Value Report (2023)

Methodological Note (2024)
Transfer of Value Report (2024)